← All indications
Rhinitis, Allergic, Seasonal
Allergic rhinitis that occurs at the same time every year. It is characterized by acute CONJUNCTIVITIS with lacrimation and ITCHING, and regarded as an allergic condition triggered by specific ALLERGENS.
Drugs by status
Approved for this indication (40)
- montelukast
- phenylephrine
- azelastine
- fluticasone
- ciclesonide
- urea
- cetirizine
- loratadine
- diphenhydramine
- mometasone
- cromoglicic acid
- cyproheptadine
- prednisone
- dexchlorpheniramine maleate
- fexofenadine
- grazax
- beclomethasone
- ephedrine
- ipratropium
- levocetirizine
- atropine
- clemastine
- triamcinolone
- budesonide
- desloratadine
- camphor
- carbinoxamine maleate
- ectoine
- acrivastine
- chlorcyclizine
- +10 more
Phase 4 trials (10)
Phase 3 trials (23)
- setipiprant
- bifidobacterium animalis
- pranlukast
- epinastine
- omalizumab
- ketorolac
- birch allergen
- epinephrine
- house dust mite allergen
- short ragweed pollen allergen
- resveratrol
- trifolium pratense
- autologous microbiome
- chlorpheniramine
- artemisia
- meadow fescue grass pollen allergen
- Lactobacillus acidophilus
- alk alutard 5-grasses
- lolium perenne pollen
- Pollinex Quattro Grass
- mg-k10
- gr1802
- Pumecitinib
Phase 2 trials (41)
- tolamba
- asp4070
- bi 67100
- bi 671800
- carbon dioxide
- chitin
- imatinib
- gsk-1004723
- gsk-256066
- gsk 835726
- ono-4053
- histamine
- petasites hybridus leaf extract
- oxybutynin
- qav-680
- r926112
- rbet v1-fv
- bepotastine
- rev131
- rv568
- asapiprant
- sch 900538
- sparc1310
- estradiol
- ur-63325
- vak694
- dna vaccine for ragweed allergen
- dnak
- iodixanol
- chickpea
- +11 more
Phase 1 trials (7)
Organizations
Organization Involved with Phase 4 Indications (24)
- Meda
- Pfizer
- Sanofi
- Alcon
- Allergopharma GmbH & Co. KG
- Bayer
- Western Sky Medical Research
- Hoosier Cancer Research Network
- Medical University of Lodz
- Monash University
- Queen's University, Belfast
- Radboud University
- Association Asthma, Bulgaria
- University of Chicago
- Medical University of Sofia
- Karolinska Institute
- Cliantha Research Limited
- ALK-Abello, S.A.
- University of Lodz
- Nasaleze
- Integrated Therapeutics Group
- University of Helsinki
- Government of Poland
- Meda Pharmaceuticals
Organization Involved with Phase 3 Indications (37)
- Actavis
- Actelion
- Sandoz
- Allergy Therapeutics
- AstraZeneca
- Stallergenes
- Perrigo
- Apotex
- ASIT Biotech S.A.
- Allergan
- Faes Farma, S.A.
- HAL Allergy
- Leti Pharma GmbH
- Magna Pharmaceuticals, Inc.
- Sunovion
- Teva
- University of London
- Lund University
- Luigi Sacco University Hospital
- University of Milan
- Capital Medical University
- Glenmark Pharmaceuticals
- Amneal Pharmaceuticals
- University of Strasbourg
- Novum Pharmaceutical Research Services
- Pharmaceutical Research Associates, Inc. (PRA)
- Watson Pharmaceuticals
- Universitair Ziekenhuis Gent
- University of Pilsen
- PHT Corporation
- +7 more
Organization Involved with Phase 2 Indications (69)
- PPD
- 3E Therapeutics Corporation
- RespiVert
- Regeneron
- Ligand Pharmaceuticals
- ISTA Pharmaceuticals
- Biomay AG
- Astellas
- Bausch & Lomb
- Shionogi
- AOBiome LLC
- Aldeyra Therapeutics, Inc.
- CMP Therapeutics Ltd
- Circassia Limited
- Danisco
- Evolutec Group
- Immunomic Therapeutics, Inc.
- Inmunotek S.L.
- Max Zeller Soehne AG
- ORA, Inc.
- Parexel
- Palau Pharma S.A.
- Rigel Pharmaceuticals
- Yakult Honsha Co., LTD
- Boehringer Ingelheim
- Cytos Biotechnology AG
- Dynavax Technologies Corporation
- National Institute of Allergy and Infectious Diseases (NIAID)
- Hospital Universitario Getafe
- Katholieke Universiteit Leuven
- +39 more
Organization Involved with Phase 1 Indications (10)
Organization Involved with Other Experimental Indications (16)
- NIZO Food Research
- German Research Foundation
- Maastricht University
- Rijnstate Hospital
- University of Florida
- University of Oslo
- University of Oulu
- Wageningen University
- Allergologiepraktijk, Arnhem
- University of Mississippi
- Humboldt University
- Wakunaga Pharmaceutical Co., Ltd.
- FrieslandCampina
- Finnish Institute of Occupational Health
- Kyowa Hakko Kogyo
- Nestle